0.12
-0.0277(-18.50%)
Currency In USD
| Previous Close | 0.15 |
| Open | 0.13 |
| Day High | 0.16 |
| Day Low | 0.12 |
| 52-Week High | 4.95 |
| 52-Week Low | 0.11 |
| Volume | 169.63M |
| Average Volume | 17.5M |
| Market Cap | 1.96M |
| PE | -0.04 |
| EPS | -2.91 |
| Moving Average 50 Days | 0.5 |
| Moving Average 200 Days | 1.8 |
| Change | -0.03 |
If you invested $1000 in GlucoTrack, Inc. (GCTK) 10 years ago, it would be worth $1.63 as of January 15, 2025 at a share price of $0.122. Whereas If you bought $1000 worth of GlucoTrack, Inc. (GCTK) shares 5 years ago, it would be worth $15.64 as of January 15, 2025 at a share price of $0.122.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Glucotrack to Present at TechBio Showcase™ 2025
GlobeNewswire Inc.
Jan 07, 2025 9:05 PM GMT
Presentation to feature an update on the Company’s novel continuous blood glucose monitor for patients with diabetesRUTHERFORD, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical techn
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR
GlobeNewswire Inc.
Dec 03, 2024 1:30 PM GMT
Feasibility study underway for the Company’s novel continuous blood glucose monitor in patients with diabetes, with data expected within 6-8 weeks Rutherford, NJ, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or th
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
GlobeNewswire Inc.
Nov 14, 2024 9:30 PM GMT
Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the closing of a “b